Translational Medicine Lessons From Flurizan's Failure in Alzheimer's Disease (AD) Trial: Implication for Future Drug Discovery and Development for AD

Clinical and Translational Science - United Kingdom
doi 10.1111/j.1752-8062.2009.00121.x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Microbial-Generated Amyloids and Alzheimer's Disease (AD)

Frontiers in Aging Neuroscience
AgingCognitive Neuroscience
2015English

Is Hyperhomocysteinemia an Alzheimer's Disease (AD) Risk Factor, an AD Marker, or Neither?

Trends in Pharmacological Sciences
ToxicologyPharmacology
2011English

3D Neuronal Culture Model of Alzheimer's Disease (AD)

Science-Business eXchange
2014English

Drug Development for Alzheimer's Disease: Recent Progress

Experimental Neurobiology
Molecular NeuroscienceNeurologyCellular
2010English

From Pg to AD: Research Finds a Link Between Gum Disease and Alzheimer's

BDJ Team
2019English

A New Roadmap for Drug Development for Alzheimer's Disease

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2013English

Early-Onset Alzheimer's Disease: Nonamnestic Subtypes and Type 2 AD

Archives of Medical Research
Medicine
2012English

Selecting for Neurogenic Potential as an Alternative for Alzheimer's Disease Drug Discovery

Alzheimer's and Dementia
Molecular NeuroscienceGerontologyHealth PolicyDevelopmental NeuroscienceMental HealthEpidemiologyGeriatricsCellularPsychiatryNeurology
2016English

Alzheimer's Disease (AD)-Like Pathology in Aged Monkeys After Infantile Exposure to Environmental Metal Lead (Pb): Evidence for a Developmental Origin and Environmental Link for AD

Journal of Neuroscience
Neuroscience
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy